Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Infinigence | Xuhui | Series C | $343.7M | 2026-10-12 |
| Xellar Biosystems | Newton | Series A | $29.5M | 2026-06-30 |
| Angitia Biopharmaceuticals | Westlake Village | Series D | $130.0M | 2026-02-05 |
| Bespin Global | Seoul | Series D | $60.0M | 2022-12-09 |
| Volant Aerotech | Minhang | Series C | $147.4M | 2026-05-27 |
| Chaitin Tech | Beijing | Series B | $71.9M | 2026-01-27 |
| Inceptio Technology | Shanghai | Series B | $188.0M | 2022-02-28 |
| Delova Biotech | Qixia | Series C | $88.6M | 2026-07-22 |
8 rows of the CSV in 5 of its 18 columns.
- The 103 Legend Capital portfolio companies have raised $6.1B in total.
- 18 of them closed their most recent round in the last 12 months, $1.4B combined.
- The largest of those rounds is Infinigence's $343.7M Series C, dated October 2026.
- DCM Ventures is an investor in 7 of them, more than any other fund.
- Software is the most common sector, with 69 companies (67%).
- 15% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 51 to 100 employees (26% of companies with a recorded size).
- 2 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 103| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Infinigence | Infinigence develops AI infrastructure and computing solutions for training and deploying AI models. | Artificial intelligence | Xuhui, China | Series C | $343.7M | 2026-10-12 | $587.5M | Qiming Venture Partners, Legend Capital | 51 to 100 | 2023 |
| Sinsegye | Sinsegye develops and sells products to meet customer needs. | Artificial intelligence | Nanshan, China | Series B | $44.6M | 2026-08-20 | $156.1M | Legend Capital, Lenovo Capital and Incubator Group (LCIG), Cowin Capital +2 | 101 to 250 | 2022 |
| Diyingjia Technology | Diyingjia Technology develops artificial intelligence software for medical imaging and treatment applications. | Artificial intelligence | Beijing, China | Series C | $3.0M | 2026-07-28 | $32.3M | IDG Capital, Legend Capital, Microsoft Accelerator | 11 to 50 | 2017 |
| Delova Biotech | Delova Biotech develops treatments for pain management. | Biotech | Qixia, China | Series C | $88.6M | 2026-07-22 | $109.8M | Legend Capital, Peakview Capital, Hyfinity Investments +1 | 51 to 100 | 2017 |
| Polarisic | Polarisic designs chips and manufactures image sensors for various applications. | Hardware | Wuhan, China | Series A | $14.7M | 2026-07-10 | $51.0M | Legend Capital, Hongtai Fund, Boyu Capital +2 | 51 to 100 | 2021 |
| Xellar Biosystems | Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. | Artificial intelligence | Newton, United States | Series A | $29.5M | 2026-06-30 | $93.2M | Legend Capital, Tiantu Capital, Zhengxuan Investment +1 | 11 to 50 | 2022 |
| Lingtai Krypton Biotechnology | Lingtai Krypton Biotechnology develops lncRNA drugs to treat human diseases. | Biotech | Shuangliu, China | Series A | $13.7M | 2026-06-26 | $13.7M | Legend Capital, Guosheng Capital, Firefly Haoyue | 11 to 50 | 2021 |
| TuringQ | TuringQ researches quantum information and manufactures optical quantum chips and computers. | Artificial intelligence | Shanghai, China | Series B | $13.9M | 2026-04-27 | $45.3M | Legend Capital, Lenovo Capital and Incubator Group (LCIG), Oriza Holdings +2 | 101 to 250 | 2021 |
| Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village, United States | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| RobotMeta | RobotMeta is an AI and robotics company based in Shenzhen, China. | Artificial intelligence | Shenzhen, China | Series B | $14.4M | 2026-02-02 | $30.0M | Legend Capital, Green Pine Capital Partners, GRC SinoGreen Fund | 51 to 100 | 2017 |
| Chaitin Tech | Chaitin Tech provides technology-driven cybersecurity solutions. | Cybersecurity | Beijing, China | Series B | $71.9M | 2026-01-27 | $232.5M | Matrix Partners China, ZhenFund, Qiming Venture Partners +1 | 101 to 250 | 2014 |
| SpacemiT | SpacemiT develops computing chips with a natively integrated cloud-edge-device architecture. | Hardware | Hangzhou, China | Series B | $86.1M | 2026-01-15 | $99.8M | ZhenFund, Legend Capital, Lenovo Capital and Incubator Group (LCIG) +1 | 51 to 100 | 2021 |
| Alioth | Alioth develops and applies technical products for pharmaceutical process technology. | Biotech | Shanghai, China | Series B | $14.4M | 2026-01-15 | $54.7M | Matrix Partners China, Legend Capital | 51 to 100 | 2021 |
| Tailan New Energy | Tailan New Energy develops solid-state batteries. | Energy | Beijing, China | Series B | $57.2M | 2025-12-31 | $57.2M | Legend Capital, CICC, China Merchants Venture Capital | 51 to 100 | 2021 |
| Allink Biotherapeutics | Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. | Biotech | Shanghai, China | Series A | $47.0M | 2025-12-16 | $89.0M | Legend Capital, Gaorong Capital, BioVenture +2 | 11 to 50 | 2023 |
| Qingwei Intelligent Technology | Qingwei Intelligent Technology makes artificial intelligence chips in China. | Artificial intelligence | Beijing, China | Series C | $282.9M | 2025-12-02 | $313.2M | Legend Capital, Z&Y Capital | 51 to 100 | 2018 |
| DK MedTech | DK MedTech manufactures vascular interventional medical device products. | Health care | Suzhou, China | Series E | $24.5M | 2024-06-21 | $36.2M | Qiming Venture Partners, Legend Capital, Oriza Seed Capital (Oriza Yuandian) +1 | 251 to 500 | 2015 |
| LYNK Pharmaceuticals | LYNK Pharmaceuticals is a biotech company that discovers and develops new medicines. | Biotech | Hangzhou, China | Series C | $16.7M | 2023-09-21 | Legend Capital, Kaitai Capital, New Alliance Capital +2 | 11 to 50 | 2018 | |
| DentaFilm | DentaFilm provides oral intelligent equipment and a full-chain platform focused on digital cloud platforms. | Health care | Hefei, China | Series B | $14.5M | 2023-04-18 | Legend Capital | 11 to 50 | 2019 | |
| Bespin Global | Bespin Global provides consulting, migration, managed services, and hybrid cloud solutions. | Software | Seoul, South Korea | Series D | $60.0M | 2022-12-09 | Legend Capital, STIC Investment, Abu Dhabi Investment Office (ADIO) | 1,001 to 5,000 | 2015 | |
| XSKY Data Technology | XSKY Data Technology provides software-defined infrastructure products and services from China. | Software | Haidian, China | Series F | $12.0M | 2022-12-01 | New Enterprise Associates, Qiming Venture Partners, Redpoint +1 | 51 to 100 | 2015 | |
| Inceptio Technology | Inceptio Technology develops autonomous trucks and their logistics networks. | Artificial intelligence | Shanghai, China | Series B | $188.0M | 2022-02-28 | Legend Capital | 501 to 1,000 | 2018 | |
| Feiyu | Feiyu operates an online platform for purchasing luxury trading bags. | Commerce | Jiading, China | Series B | $30.0M | 2021-06-02 | Matrix Partners China, Legend Capital, N5Capital +1 | 1 to 10 | 2016 | |
| Bloks Technology Group | Bloks Technology Group uses technology to create product experiences and long-term user value. | Education | Minhang, China | Series B | $93.2M | 2021-05-14 | Legend Capital, Source Code Capital, Gaorong Capital +1 | 101 to 250 | 2014 | |
| StoneWise | StoneWise builds an intelligent drug discovery platform for pharmaceutical research. | Artificial intelligence | Haidian, China | Series B | $100.0M | 2021-04-12 | Legend Capital, Luminous Ventures (former Lightspeed China Partners), Hillhouse Ventures +1 | 51 to 100 | 2018 | |
| DXY Unicorn | DXY is an online healthcare community connecting doctors, consumers, and healthcare organizations. | Biotech | Hangzhou, China | Series E | $500.0M | 2020-12-29 | $682.0M | Shunwei Capital, DCM Ventures, Legend Capital +1 | 101 to 250 | 2000 |
| Wanxue Education | Wanxue Haiwen provides non-academic courses for people holding degrees above a Bachelor's. | Education | Beijing, China | Series D | $100.0M | 2020-01-15 | Sequoia Capital, DCM Ventures, Legend Capital +1 | 5,001 to 10,000 | 1988 | |
| Santouliubi | Santouliubi provides enterprise cloud communication services. | Software | Fengtai, China | Series A | $14.0M | 2019-09-23 | Legend Capital | 11 to 50 | 2013 | |
| Jollychic Unicorn | Jollychic operates an e-commerce platform selling clothing and accessories online. | Commerce | Hangzhou, China | Series C | $65.0M | 2019-08-05 | Legend Capital, CDH Investments, Orchid Asia Group Management +1 | 1,001 to 5,000 | 2012 | |
| Onion Math | Onion Math operates an online education platform. | Education | Beijing, China | Series D | $44.7M | 2019-04-22 | Legend Capital, Frees Fund, Yunqi Partners +1 | 1,001 to 5,000 | 2013 |
Table 1. Legend Capital portfolio companies: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 103.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Infinigence | Infinigence develops AI infrastructure and computing solutions for training and deploying AI models. | Artificial intelligence | Xuhui, China | Series C | $343.7M | 2026-10-12 | $587.5M | Qiming Venture Partners, Legend Capital | 51 to 100 | 2023 |
| 2 | Qingwei Intelligent Technology | Qingwei Intelligent Technology makes artificial intelligence chips in China. | Artificial intelligence | Beijing, China | Series C | $282.9M | 2025-12-02 | $313.2M | Legend Capital, Z&Y Capital | 51 to 100 | 2018 |
| 3 | Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village, United States | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| 4 | Delova Biotech | Delova Biotech develops treatments for pain management. | Biotech | Qixia, China | Series C | $88.6M | 2026-07-22 | $109.8M | Legend Capital, Peakview Capital, Hyfinity Investments +1 | 51 to 100 | 2017 |
| 5 | SpacemiT | SpacemiT develops computing chips with a natively integrated cloud-edge-device architecture. | Hardware | Hangzhou, China | Series B | $86.1M | 2026-01-15 | $99.8M | ZhenFund, Legend Capital, Lenovo Capital and Incubator Group (LCIG) +1 | 51 to 100 | 2021 |
| 6 | Chaitin Tech | Chaitin Tech provides technology-driven cybersecurity solutions. | Cybersecurity | Beijing, China | Series B | $71.9M | 2026-01-27 | $232.5M | Matrix Partners China, ZhenFund, Qiming Venture Partners +1 | 101 to 250 | 2014 |
| 7 | Tailan New Energy | Tailan New Energy develops solid-state batteries. | Energy | Beijing, China | Series B | $57.2M | 2025-12-31 | $57.2M | Legend Capital, CICC, China Merchants Venture Capital | 51 to 100 | 2021 |
| 8 | Allink Biotherapeutics | Allink Biotherapeutics develops multi-specific antibodies for treating cancer and immune disorders. | Biotech | Shanghai, China | Series A | $47.0M | 2025-12-16 | $89.0M | Legend Capital, Gaorong Capital, BioVenture +2 | 11 to 50 | 2023 |
| 9 | Sinsegye | Sinsegye develops and sells products to meet customer needs. | Artificial intelligence | Nanshan, China | Series B | $44.6M | 2026-08-20 | $156.1M | Legend Capital, Lenovo Capital and Incubator Group (LCIG), Cowin Capital +2 | 101 to 250 | 2022 |
| 10 | Xellar Biosystems | Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. | Artificial intelligence | Newton, United States | Series A | $29.5M | 2026-06-30 | $93.2M | Legend Capital, Tiantu Capital, Zhengxuan Investment +1 | 11 to 50 | 2022 |
Table 2. Legend Capital portfolio companies: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | DCM Ventures | Venture capital firm | Menlo Park, United States | 7 | 7% | ||
| 2 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 6 | 6% | 4 | Sinsegye, TuringQ, Open Source China |
| 3 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 5 | 5% | 2 | Infinigence, Chaitin Tech |
| 4 | Matrix Partners China | Venture capital firm | Beijing, China | 4 | 4% | 2 | Chaitin Tech, Alioth |
| 5 | ZhenFund | Entrepreneurship program | Beijing, China | 4 | 4% | 2 | Chaitin Tech, SpacemiT |
| 6 | Gaorong Capital | Venture capital firm | Wangjing, China | 4 | 4% | 1 | Allink Biotherapeutics |
| 7 | Shunwei Capital | Venture capital firm | Beijing, China | 3 | 3% | 1 | Volant Aerotech |
| 8 | GL Ventures LLC | Venture capital firm | Beijing, China | 3 | 3% | ||
| 9 | IDG Capital | Private equity firm | Beijing, China | 3 | 3% | 1 | Diyingjia Technology |
| 10 | Frees Fund | Venture capital firm | Beijing, China | 3 | 3% | ||
| 11 | Northern Light Venture Capital | Venture capital firm | Beijing, China | 3 | 3% | ||
| 12 | K2VC | Angel group | Beijing, China | 3 | 3% | ||
| 13 | GGV Capital | Venture capital firm | Menlo Park, United States | 3 | 3% | ||
| 14 | Luminous Ventures (former Lightspeed China Partners) | Venture capital firm | Shanghai, China | 2 | 2% | ||
| 15 | Oriza Holdings | Venture capital firm | Suzhou, China | 2 | 2% | 2 | TuringQ, Angitia Biopharmaceuticals |
Table 3. Legend Capital portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 69 | 67% | $4.1B |
| Artificial intelligence | 22 | 21% | $1.4B |
| Hardware | 19 | 18% | $1.6B |
| Health care | 18 | 17% | $1.8B |
| Biotech | 14 | 14% | $1.7B |
| Fintech | 12 | 12% | $9.5M |
| Commerce | 11 | 11% | $1.6B |
| Education | 8 | 8% | |
| Energy | 3 | 3% | $57.2M |
| Cybersecurity | 1 | 1% | $232.5M |
Table 4. Legend Capital portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Legend Capital portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| China | 95 | 92% |
| United States | 5 | 5% |
| South Korea | 2 | 2% |
| Indonesia | 1 | 1% |
Table 6. Legend Capital portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Legend Capital portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 6% | $343.7M |
| August 2026 | 1 | 6% | $44.6M |
| July 2026 | 3 | 17% | $106.4M |
| June 2026 | 2 | 11% | $43.1M |
| May 2026 | 1 | 6% | $147.4M |
| April 2026 | 2 | 11% | $13.9M |
| February 2026 | 2 | 11% | $144.4M |
| January 2026 | 3 | 17% | $172.3M |
| December 2025 | 3 | 17% | $387.1M |
Table 8. Legend Capital portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 15 | 15% | $1.0B |
| 2025 | 5 | 5% | $414.7M |
| 2024 | 6 | 6% | $121.6M |
| 2023 | 9 | 9% | $168.6M |
| 2022 | 12 | 12% | $426.8M |
| 2021 | 8 | 8% | $635.2M |
Table 9. Legend Capital portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 2% |
| 2020 to 2022 | 13 | 13% |
| 2015 to 2019 | 41 | 40% |
| 2010 to 2014 | 29 | 28% |
| Before 2010 | 18 | 17% |
Table 10. Legend Capital portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 5 | 5% |
| 11 to 50 | 21 | 21% |
| 51 to 100 | 25 | 26% |
| 101 to 250 | 15 | 15% |
| 251 to 500 | 13 | 13% |
| 501 to 1,000 | 11 | 11% |
| 1,001 to 5,000 | 6 | 6% |
| 5,001 to 10,000 | 1 | 1% |
| 10,001 or more | 1 | 1% |
Table 11. Legend Capital portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Legend Capital is recorded as one of its investors. On 16 November 2026 that is 103 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 103 rows: 27 have no round amount, 0 no city and 51 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Legend Capital portfolio companies are on the list?
- 103, in the file dated 16 November 2026. 18 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 103 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.